Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Nov 1;98(9):1966–1970. doi: 10.1172/JCI119000

Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver.

M Véniant 1, J Ménard 1, P Bruneval 1, S Morley 1, M F Gonzales 1, J Mullins 1
PMCID: PMC507639  PMID: 8903314

Abstract

We have developed a transgenic animal model to investigate the effects of overexpression of rat prorenin on the cardiovascular system. Two transgenic rat lines were generated in which rat prorenin expression was directed to the liver by a human alpha1-antitrypsin promoter. Liver-specific expression was confirmed by RNase protection assay. Plasma prorenin concentrations in transgenic rats were increased 400-fold in the males of both lines but were increased only two- to threefold in the females. Thus, transgene expression exhibited sexual dimorphism. Blood pressures were not significantly higher in transgenic rats than in nontransgenic controls. The ratio of heart weight to body weight was greater in male transgenic rats than in the nontransgenic controls. Histological analysis revealed severe renal lesions and hypertrophic cardiomyocytes in transgenic males only. This transgenic model demonstrates a likely role of prorenin in the development of cardiac and renal pathology independent of hypertension. These animals will facilitate studies of the effects of blockade of the renin-angiotensin system and other pharmacological interventions on the development and treatment of cardiac, vascular, and renal lesions induced by changes in this system in the absence of chronic hypertension.

Full Text

The Full Text of this article is available as a PDF (470.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman M. H., Madhavan S., Ooi W. L., Cohen H., Sealey J. E., Laragh J. H. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med. 1991 Apr 18;324(16):1098–1104. doi: 10.1056/NEJM199104183241605. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. Brunner H. R., Laragh J. H., Baer L., Newton M. A., Goodwin F. T., Krakoff L. R., Bard R. H., Bühler F. R. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med. 1972 Mar 2;286(9):441–449. doi: 10.1056/NEJM197203022860901. [DOI] [PubMed] [Google Scholar]
  4. Cambien F. The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction. Clin Genet. 1994 Jul;46(1 Spec No):94–101. doi: 10.1111/j.1399-0004.1994.tb04210.x. [DOI] [PubMed] [Google Scholar]
  5. Campbell D. J., Valentijn A. J. Identification of vascular renin-binding proteins by chemical cross-linking: inhibition of binding of renin by renin inhibitors. J Hypertens. 1994 Aug;12(8):879–890. [PubMed] [Google Scholar]
  6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  7. Da Silva J. L., Lacombe C., Bruneval P., Casadevall N., Leporrier M., Camilleri J. P., Bariety J., Tambourin P., Varet B. Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood. 1990 Feb 1;75(3):577–582. [PubMed] [Google Scholar]
  8. Derkx F. H., de Bruin R. J., van Gool J. M., Rosmalen F. M., van Hoek M. J., Beerendonk C. C., Schalekamp M. A. A novel assay of plasma prorenin using a renin inhibitor. J Hypertens Suppl. 1993 Dec;11(5):S240–S241. [PubMed] [Google Scholar]
  9. Dzau V. J. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes. Curr Opin Nephrol Hypertens. 1993 Jan;2(1):27–32. doi: 10.1097/00041552-199301000-00004. [DOI] [PubMed] [Google Scholar]
  10. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  11. Heinrikson R. L., Hui J., Zürcher-Neely H., Poorman R. A. A structural model to explain the partial catalytic activity of human prorenin. Am J Hypertens. 1989 May;2(5 Pt 1):367–380. doi: 10.1093/ajh/2.5.367. [DOI] [PubMed] [Google Scholar]
  12. Hilgers K. F., Peters J., Veelken R., Sommer M., Rupprecht G., Ganten D., Luft F. C., Mann J. F. Increased vascular angiotensin formation in female rats harboring the mouse Ren-2 gene. Hypertension. 1992 Jun;19(6 Pt 2):687–691. doi: 10.1161/01.hyp.19.6.687. [DOI] [PubMed] [Google Scholar]
  13. Hsueh W. A., Baxter J. D. Human prorenin. Hypertension. 1991 Apr;17(4):469–477. doi: 10.1161/01.hyp.17.4.469. [DOI] [PubMed] [Google Scholar]
  14. Jallat S., Perraud F., Dalemans W., Balland A., Dieterle A., Faure T., Meulien P., Pavirani A. Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines. EMBO J. 1990 Oct;9(10):3295–3301. doi: 10.1002/j.1460-2075.1990.tb07529.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jeunemaitre X., Soubrier F., Kotelevtsev Y. V., Lifton R. P., Williams C. S., Charru A., Hunt S. C., Hopkins P. N., Williams R. R., Lalouel J. M. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992 Oct 2;71(1):169–180. doi: 10.1016/0092-8674(92)90275-h. [DOI] [PubMed] [Google Scholar]
  16. Johannessen A., Nielsen A. H., Poulsen K. Sexual dimorphism of inactive renin in rat plasma. Clin Exp Hypertens A. 1990;12(8):1405–1417. doi: 10.3109/10641969009073527. [DOI] [PubMed] [Google Scholar]
  17. Leckie B. J., McGhee N. K. Reversible activation-inactivation of renin in human plasma. Nature. 1980 Dec 25;288(5792):702–705. doi: 10.1038/288702a0. [DOI] [PubMed] [Google Scholar]
  18. Lenz T., Sealey J. E., Maack T., James G. D., Heinrikson R. L., Marion D., Laragh J. H. Half-life, hemodynamic, renal, and hormonal effects of prorenin in cynomolgus monkeys. Am J Physiol. 1991 Apr;260(4 Pt 2):R804–R810. doi: 10.1152/ajpregu.1991.260.4.R804. [DOI] [PubMed] [Google Scholar]
  19. Menard J., Catt K. J. Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology. 1972 Feb;90(2):422–430. doi: 10.1210/endo-90-2-422. [DOI] [PubMed] [Google Scholar]
  20. Mullins J. J., Peters J., Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990 Apr 5;344(6266):541–544. doi: 10.1038/344541a0. [DOI] [PubMed] [Google Scholar]
  21. Nagahama M., Nakayama K., Murakami K. Sequence requirements for prohormone processing in mouse pituitary AtT-20 cells. Analysis using prorenins as model substrates. Eur J Biochem. 1991 Apr 10;197(1):135–140. doi: 10.1111/j.1432-1033.1991.tb15891.x. [DOI] [PubMed] [Google Scholar]
  22. Nielsen A. H., Poulsen K. Is prorenin of physiological and clinical significance? J Hypertens. 1988 Dec;6(12):949–958. doi: 10.1097/00004872-198812000-00001. [DOI] [PubMed] [Google Scholar]
  23. Nukiwa T., Satoh K., Brantly M. L., Ogushi F., Fells G. A., Courtney M., Crystal R. G. Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene. J Biol Chem. 1986 Dec 5;261(34):15989–15994. [PubMed] [Google Scholar]
  24. Osmond D. H., Sealey J. E., McKenzie J. K. Activation and function of prorenin: different viewpoints. Can J Physiol Pharmacol. 1991 Sep;69(9):1308–1314. doi: 10.1139/y91-193. [DOI] [PubMed] [Google Scholar]
  25. Reudelhuber T. L., Ramla D., Chiu L., Mercure C., Seidah N. G. Proteolytic processing of human prorenin in renal and non-renal tissues. Kidney Int. 1994 Dec;46(6):1522–1524. doi: 10.1038/ki.1994.435. [DOI] [PubMed] [Google Scholar]
  26. Schelling P., Fischer H., Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens. 1991 Jan;9(1):3–15. [PubMed] [Google Scholar]
  27. Sealey J. E., Atlas S. A., Laragh J. H. Prorenin and other large molecular weight forms of renin. Endocr Rev. 1980 Fall;1(4):365–391. doi: 10.1210/edrv-1-4-365. [DOI] [PubMed] [Google Scholar]
  28. Sealey J. E., Rubattu S. Prorenin and renin as separate mediators of tissue and circulating systems. Am J Hypertens. 1989 May;2(5 Pt 1):358–366. doi: 10.1093/ajh/2.5.358. [DOI] [PubMed] [Google Scholar]
  29. Senanayake P. D., Moriguchi A., Kumagai H., Ganten D., Ferrario C. M., Brosnihan K. B. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides. 1994;15(5):919–926. doi: 10.1016/0196-9781(94)90051-5. [DOI] [PubMed] [Google Scholar]
  30. Sifers R. N., Carlson J. A., Clift S. M., DeMayo F. J., Bullock D. W., Woo S. L. Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice. Nucleic Acids Res. 1987 Feb 25;15(4):1459–1475. doi: 10.1093/nar/15.4.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Véniant M., Heudes D., Clozel J. P., Bruneval P., Ménard J. Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats. Kidney Int. 1994 Aug;46(2):421–429. doi: 10.1038/ki.1994.290. [DOI] [PubMed] [Google Scholar]
  32. Véniant M., Whitworth C. E., Ménard J., Sharp M. G., Gonzales M. F., Bruneval P., Mullins J. J. Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mRen2)27 rats. Am J Hypertens. 1995 Dec;8(12 Pt 1):1167–1176. doi: 10.1016/0895-7061(95)00254-5. [DOI] [PubMed] [Google Scholar]
  33. Wilson D. M., Luetscher J. A. Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med. 1990 Oct 18;323(16):1101–1106. doi: 10.1056/NEJM199010183231604. [DOI] [PubMed] [Google Scholar]
  34. Yamaguchi T., Tokita Y., Franco-Saenz R., Mulrow P. J., Peters J., Ganten D. Zonal distribution and regulation of adrenal renin in a transgenic model of hypertension in the rat. Endocrinology. 1992 Oct;131(4):1955–1962. doi: 10.1210/endo.131.4.1396339. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES